UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$646M |
| 2 |
Automatic Data Processing
ADP
|
+$510M |
| 3 |
Baidu
BIDU
|
+$349M |
| 4 |
Tesla
TSLA
|
+$320M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$758M |
| 2 |
Shopify
SHOP
|
+$568M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$521M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Communication Services | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2301
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $664K | ﹤0.01% |
13,426
+1,443
| +12% | +$69.3K |
|
2302
BridgeBio Pharma
BBIO
$16.6B
| $664K | ﹤0.01% |
65,459
+498
| +0.8% | +$5.11K |
|
2303
Ranpak Holdings
PACK
$456M
| $663K | ﹤0.01% |
32,476
-4,391
| -12% | -$115K |
|
|
EXK
2304
Endeavour Silver
EXK
$3B
| $663K | ﹤0.01% |
142,791
| – | – |
|
2305
Argan
AGX
$8.32B
| $658K | ﹤0.01% |
16,205
| – | – |
|
2306
Bank First Corp
BFC
$1.7B
| $655K | ﹤0.01% |
9,104
+2,100
| +30% | +$150K |
|
2307
Aurinia Pharmaceuticals
AUPH
$2.06B
| $653K | ﹤0.01% |
52,740
-88,719
| -63% | -$1.37M |
|
2308
Relmada Therapeutics
RLMD
$503M
| $651K | ﹤0.01% |
+24,120
| New | +$499K |
|
2309
Liberty Media Series A
FWONA
$23.5B
| $648K | ﹤0.01% |
10,725
| – | – |
|
2310
Tootsie Roll Industries
TR
$2.98B
| $647K | ﹤0.01% |
20,822
-3
| -0% | -$90 |
|
2311
Clearfield
CLFD
$371M
| $647K | ﹤0.01% |
+9,913
| New | +$622K |
|
2312
John B. Sanfilippo & Son
JBSS
$965M
| $646K | ﹤0.01% |
7,737
| – | – |
|
|
TPC
2313
Tutor Perini Cor
TPC
$5.28B
| $645K | ﹤0.01% |
59,750
+22,868
| +62% | +$256K |
|
2314
Star Group
SGU
$418M
| $643K | ﹤0.01% |
57,961
-5,503
| -9% | -$57.6K |
|
2315
Tucows
TCX
$152M
| $642K | ﹤0.01% |
9,400
| – | – |
|
|
RADI
2316
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $640K | ﹤0.01% |
44,850
-69
| -0.2% | -$962 |
|
|
XM
2317
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $636K | ﹤0.01% |
22,294
+5,298
| +31% | +$153K |
|
|
THR
2318
DELISTED
Thermon Group Holdings
THR
| $635K | ﹤0.01% |
39,214
| – | – |
|
2319
Hawkins
HWKN
$2.72B
| $634K | ﹤0.01% |
13,822
+7,789
| +129% | +$328K |
|
2320
Heron Therapeutics
HRTX
$71.2M
| $634K | ﹤0.01% |
110,752
-256
| -0.2% | -$1.87K |
|
2321
Rigel Pharmaceuticals
RIGL
$765M
| $630K | ﹤0.01% |
21,058
| – | – |
|
2322
Resources Connection
RGP
$148M
| $628K | ﹤0.01% |
36,667
| – | – |
|
2323
Janus International
JBI
$735M
| $628K | ﹤0.01% |
69,807
+30,807
| +79% | +$313K |
|
|
CVGW
2324
DELISTED
Calavo Growers
CVGW
| $628K | ﹤0.01% |
17,221
| – | – |
|
2325
Holley
HLLY
$382M
| $627K | ﹤0.01% |
+45,111
| New | +$579K |
|
Similar funds
UBS AM's Q1 2022 Portfolio in Review
As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Baidu worth $306M.
- UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
- UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
- UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
- UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
- UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
- UBS AM opened 60 new positions and closed 124 in Q1 2022.
- UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.